We last reviewed the charts of Perrigo Corp. (PRGO) on April 9, 2020. We wrote that "After dealing with a drug recall fiasco two years ago I cannot wait for drugs and supplements to be made in the U.S. again. I guess I have some skin in the game when I look at PRGO. Traders could approach the long side of PRGO at current levels, risking a close below $41. Our initial upside price target is $56."
More from Stocks
There are three basic ways to manage luck. The best traders use all three in varying amounts.
While struggles are likely ahead, this is exactly what we need.
When growth starts to slow and inflation moves higher - that's the most unfavorable set of conditions. And that's exactly the market's nervousness right now.